Trusted medical support in China for Mongolian patients
Cross-border care assistance · Standard service
China–Mongolia cross-border medical consultation is available. Contact us by phone or Facebook.Partner of the Third Central Hospital of Mongolia
Back to doctors
Bing Yun Tao
Associate Chief Physician

Peking University Third Hospital · General Surgery Department · Beijing

2023.8—,,; 201 8.8—2023.8,,; 20 15. 8 —20 18. 8,,;: 、,. 1, “ ”1, 1, SCI 10, 8.: 1.,; 2.,;: 1. 2022,: “ ”,; 2.2020, “ ” “ ”; 3. 2019, “ ” 4. 2018,: ‘ ’ ‘ ’,; 5. 2018, “ ”.: (1) Bin Jiang*, Maolin Tian*, Gang Li*, Abuduhaibaier Sadula, Dianrong Xiu#, Chunhui Yuan#, Yuntao Bing#. circEPS15 Overexpression in Hepatocellular Carcinoma Modulates Tumor Invasion and Migration.Front Genet. 2022, 13:804848. (2) Gang Li *, Yun t ao Bing *, Mao l in Tian, Chun h ui Yuan #, Dian r ong Xiu #. Using a Nomogram to Preoperatively Predict Distant Metastasis of Pancreatic Neuroendocrine Tumor in Elderly Patients. Chin Med Sci J 2021, 36(3):218-224. (3) *,, #,.., 2021, 12; 915-918. (4) *, #.., 2022, 42 (05):529-532. (5) Yuntao Bing *, Abuduhaibaier Sadula, Dianrong Xiu, Chunhui Yuan #, Laparoscopic middle segment splenectomy for central splenic hemangioma: A case report. 2020,77: 925-929. (6) Bing Y, Zhu S, Jiang K, Dong G, Li J, Yang Z, Yang J, Yue J. Reduction of thyroid hormones triggers down-regulation of hepatic CYP2B through nuclear receptors CAR and TR in a rat model of acute stroke. Biochem Pharmacol. 2014 Feb 15;87(4):636-49. (7) Bing Y, Zhu S, Yu G, Li T, Liu W, Li C, Wang Y, Qi H, Guo T, Yuan Y, He Y, Liu Z, Liu Q. Glucocorticoid-induced S-adenosylmethionine enhances the interferon signaling pathway by restoring STAT1 protein methylation in hepatitis B virus-infected cells. J Biol Chem. 2014 Nov 21;289(47):32639-55. (8) Bing Y, Tian M, Li G, Jiang B, Ma Z, Li L, Wang L, Wang H, Xiu D. Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients. Medicine (Baltimore). 2018 Aug;97(35):e12055. 《 》,,;: 1. 2023,,, 1/1; 2. 2023,,, 1/3; 3. 2023,,, 1/1; 4. 2023,,, 1/1; 5. 2023,,, 1/1; 6. 2023,,, 1/ 3; 7. 2023,,, 1/ 3;

Remove this favorite?